Related Experiment Video
Updated: May 4, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
27.9K
Changes in the thalamus in atypical parkinsonism detected using shape analysis and diffusion tensor imaging
C P Hess1, C W Christine2, A C Apple3
1From the Departments of Radiology and Biomedical Imaging (C.P.H., A.C.A., W.P.D.) Christopher.Hess@ucsf.edu.
AJNR. American Journal of Neuroradiology
|December 21, 2013
Summary
Progressive supranuclear palsy and corticobasal syndrome cause lateral thalamus atrophy and increased ADC, unlike Parkinson disease. These findings may indicate tau-related neurodegeneration.
Area of Science:
- Neuroimaging
- Neurodegeneration
- Movement Disorders
Background:
- The thalamus plays a crucial role in cognitive function and sensorimotor integration.
- It is interconnected with the nigrostriatal system and cerebral cortex.
- Understanding thalamic involvement is key in differentiating neurodegenerative diseases.
Purpose of the Study:
- To investigate regional thalamic differences in Parkinson disease (PD), progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS).
- To identify potential imaging biomarkers for distinguishing these conditions.
Main Methods:
- 3T MR imaging (volumetric T1 and diffusion tensor imaging) was performed on patients with PD, PSP, CBS, and healthy volunteers.
- Thalamic nuclear groups were delineated, and apparent diffusion coefficient (ADC) was calculated.
- Thalamic volume, shape, and ADC were compared across all groups.
Main Results:
- PSP and CBS groups showed smaller thalamic volumes compared to PD and control groups.
- Lateral thalamus atrophy was the primary contributor to volume reduction.
- Higher ADC values were observed in PSP compared to PD and controls, particularly in motor thalamic regions.
Conclusions:
- Reduced size and increased ADC disproportionately affect the lateral thalamus in PSP and CBS, suggesting selective neurodegeneration.
- These imaging findings may serve as specific markers for tau-related neurodegeneration.
- The observed thalamic changes differ between PD and tauopathies like PSP and CBS.

